DaVita
renal dialysis center chain based in the United States
DVA NYSE
ISIN US23918K1088 SEC CIK 927066 LEI M2XHYMU3TZNEZURC6H66
Follow DaVita
Weekly email: filings, results
Revenue, last quarter
$3.6B
+4.6% vs same quarter last year
Net income
$222.9M
+48.3% vs same quarter last year
EPS, diluted
$3.40
+66.7% vs same quarter last year
Operating cash flow
$518.8M
−38.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $13.6B | $1.1B |
| FY24 | $12.8B | $1.3B |
| FY23 | $12.1B | $957M |
| FY22 | $11.6B | $781.6M |
| FY21 | $11.6B | $1.2B |
| FY20 | $11.6B | $773.6M |
| FY19 | $11.4B | $811M |
| FY18 | $11.4B | $159.4M |
| FY17 | $10.9B | $663.6M |
| FY16 | $10.7B | $879.9M |
| FY15 | - | $269.7M |
| FY14 | - | $723.1M |
| FY13 | - | $633.4M |
| FY12 | - | $536M |
| FY11 | - | $478M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 15% | 7.9% |
| FY24 | 16.3% | 9.8% |
| FY23 | 13.2% | 7.9% |
| FY22 | 11.5% | 6.7% |
| FY21 | 15.5% | 10.4% |
| FY20 | 14.7% | 6.7% |
| FY19 | 14.4% | 7.1% |
| FY18 | 13.4% | 1.4% |
| FY17 | 16.7% | 6.1% |
| FY16 | 19% | 8.2% |
| FY15 | - | - |
| FY14 | - | - |
| FY13 | - | - |
| FY12 | - | - |
| FY11 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $1.3B |
| FY24 | $1.5B |
| FY23 | $1.5B |
| FY22 | $961.1M |
| FY21 | $1.3B |
| FY20 | $1.3B |
| FY19 | $1.3B |
| FY18 | $784.5M |
| FY17 | $1B |
| FY16 | $1.1B |
| FY15 | $849.2M |
| FY14 | $818.1M |
| FY13 | $1.2B |
| FY12 | $550.7M |
| FY11 | $779.9M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $1.3B |
| FY24 | $1.4B |
| FY23 | $272.2M |
| FY22 | $802.2M |
| FY21 | $1.5B |
| FY20 | $1.5B |
| FY19 | $2.4B |
| FY18 | $1.2B |
| FY17 | $802.9M |
| FY16 | $1.1B |
| FY15 | $549.9M |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | $323.3M |
- DaVita
- Healthcare median
Show the numbers
| Year | DaVita | Healthcare median |
|---|---|---|
| FY25 | 7.9% | −30.6% |
| FY24 | 9.8% | −47% |
| FY23 | 7.9% | −58% |
| FY22 | 6.7% | −80.4% |
| FY21 | 10.4% | −71.9% |
| FY20 | 6.7% | −62.2% |
| FY19 | 7.1% | −46.3% |
| FY18 | 1.4% | −49.6% |
| FY17 | 6.1% | −45.9% |
| FY16 | 8.2% | −36% |
| FY15 | - | −38.4% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |
| FY11 | - | −27.9% |